Research Article

Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies

Table 9

Effect of ubiquinol acetate on clinical chemistry parameters in male rats.

ParametersUnitsGroup & Dose (mg/kg b.w.)
G1,G2,G3,G4,G1R,G4R,
01503006000600

Glucosemg/dL129.70±18.00119.00±11.96122.10±7.68138.00±22.9132.40±10.36125.2±12.62

Blood Urea Nitrogenmg/dL16.30±1.7715.80±2.0415.50±2.1717.50±2.4211.80±0.4513.40±2.51

Creatininemg/dL0.31±0.050.34±0.080.38±0.050.37±0.050.28±0.050.30±0.04

Cholesterolmg/dL57.60±8.7157.90±7.8857.5±6.7964.00±11.3268.60±9.0768.60±8.08

TGLmg/dL47.80±13.4241.20±16.243.40±10.4640.60±8.7252.00±9.8250.6±14.42

Total Proteing/dL6.64±0.256.74±0.136.96±0.227.17±0.256.84±0.136.78±0.08

Albuming/dL1.22±0.081.25±0.11.31±0.121.23±0.111.22±0.081.18±0.13

Total Bilirubinmg/dL0.06±0.050.10±0.050.08±0.040.11±0.030.10±0.000.04±0.05

ASTU/L68.20±17.6379.80±22.7667.70±11.8081.8±20.3267.60±2.1970.00±10.84

Calciummg/dL9.26±0.359.26±0.279.31±0.399.11±0.49.62±0.229.80±0.35

Phosphorusmg/dL5.72±0.485.64±0.435.70±0.295.78±0.155.90±0.126.12±0.45

ALPU/L98.40±19.193.50±15.8894.20±13.25108.9±21.3481.80±10.6477.60±5.37

ALTU/L20.00±4.0624.10±8.4120.10±3.4825.70±7.1022.60±2.5126.40±6.11

GGTU/L2.90±1.372.10±0.743.00±1.332.70±0.826.20±0.844.80±1.92

Sodiummmol/L135.19±1.32134.40±1.05136.09±1.7134.16±1.42136.94±0.76135.7±0.61

Potassiummmol/L4.19±0.244.23±0.354.14±0.254.32±0.164.29±0.174.12±0.38

Chloridemmol/L107.13±1.19107.03±0.78107.53±0.84107.78±1.85105.60±0.82105.22±0.72

Globuling/dL5.42±0.305.49±0.185.65±0.175.94±0.315.62±0.165.60±0.16

Mean ± SD for 10 rats/sex/group (G1, G2, G3, G4) and 5 rats/sex/group (G1R, G4R);: statistically significant compared to the control group (p < 0.05).